Abstract:Abstract Probiotics are defined as live microorganisms that confer a health benefit on the host when administered in adequate amounts. Bacillus coagulans GBI-30, 6086 (BC30) is a commercially available, lactic acid-producing, spore-forming bacteria that exhibits diverse functions. Contrary to most lactic acid-producing bacteria, B. coagulans spores can withstand extreme conditions, lending resiliency through commercial pet food processing, storage, and chemical and enzymatic digestion through the gastrointestinal tract. Previous studies in humans and livestock suggest B. coagulans have probiotic potential, although research in dogs is limited. Therefore, the objectives were to determine the effects of B. coagulans on nutrient digestibility, hematology, immunoglobulin concentrations, and fecal characteristics, metabolites, and microbiota populations of healthy adult dogs before and after an abrupt diet change. Pointer dogs [n = 12; age = 5.9 ± 2.5 yr; body weight (BW) = 26.6 ± 6.1 kg] were used in a replicated 3 × 3 Latin square design and fed commercial diets containing no probiotics or prebiotics. Probiotic or placebo capsules were administered before each daily feeding, with the following treatments tested: 1) basal diet + placebo (control; 250 mg maltodextrin); 2) basal diet + B. coagulans (low dose; 5 x 108 CFU/d); and 3) basal diet + B. coagulans (high dose; 2.5 x 109 CFU/d). An extruded kibble diet was fed to all dogs during a 28-d diet transition phase, after which dogs were abruptly switched to a commercial canned diet with fecal samples collected 2-, 6-, 10-, and 14-d after diet change. All data were analyzed using the Mixed Models procedure of SAS 9.4, with P < 0.05 being significant. Prior to dietary change, nutrient digestibility, food intake, immunoglobulin concentrations, metabolites, and hematology were not affected by treatment. However, fecal scores were decreased (P < 0.05; firmer stools) in dogs fed B. coagulans than controls. Also, fecal Faecalibacterium abundance was greater (P < 0.05) in dogs fed the low B. coagulans dose than those fed the high dose or controls. There were no interaction effects observed due to B. coagulans supplementation throughout the diet transition, but the abrupt transition to canned food reduced (P < 0.0001) fecal DM content and increased (P < 0.0001) fecal scores (looser stools) and pH. The diet transition also increased (P < 0.01) fecal Clostridium hiranonis, Collinsella, Fusobacterium, and Ruminococcus gnavus abundances and decreased (P < 0.01) fecal Bifidobacterium, Blautia, Faecalibacterium, Prevotella copri, Streptococcus, and Turicibacter abundances. Abundances of E. coli, Faecalibacterium, and Prevotella copri were modulated (P < 0.05) by B. coagulans supplementation alone. Our results demonstrate that although B. coagulans did not appear to attenuate shifts in fecal consistency and microbiota populations during an abrupt dietary change, this species may aid in maintaining stool quality and does not negatively impact nutrient digestibility or canine health.

Galactoligosaccharide and a prebiotic blend improve colonic health and immunity of adult dogs

Evaluation of Probiotic and Antimicrobial Potential of Canine Derived–<em>Lactobacilli</em>

Effects of Increasing Levels of Purified Beta-1,3/1,6-Glucans on the Fecal Microbiome, Digestibility, and Immunity Variables of Healthy Adult Dogs

Effects of Supplementation of Live and Heat-treated Bifidobacterium animalis subspecies lactis CECT 8145 on Glycemic and Insulinemic Response, Fecal Microbiota, Systemic Biomarkers of Inflammation, and White Blood Cell Gene Expression of Adult Dogs.

Microbiota in Mild Inflammatory Bowel Disease (IBD) Can Be Modulated by Beta-Glucans and Mannanoligosaccharides: A Randomized, Double-Blinded Study in Dogs

Effects of dietary fiber and biotic supplementation on apparent total tract macronutrient digestibility and the fecal characteristics, metabolites, and microbiota of healthy adult dogs

PSIX-16 Effects of Bacillus coagulans GBI-30, 6086 on nutrient digestibility, fecal characteristics and metabolites, immunity, and microbiota of healthy adult dogs subjected to an abrupt diet change

Continuous intake of galacto-oligosaccharide containing syrup contributes to maintaining the health of household dogs by modulating their gut microbiota

Effects of Oligosaccharide Fermentation on Canine Gut Microbiota and Fermentation Metabolites in an In Vitro Fecal Fermentation Model

β-glucans from Euglena gracilis or Saccharomyces cerevisiae effects on immunity and inflammatory parameters in dogs

PSVIII-22 A Probiotic Blend Improves Fecal Quality and Enhances Gut Immunity in Dogs with Chronic Diarrhea

Prebiotic fiber blend supports growth and development and favorable digestive health in puppies

Oral Administration of Compound Probiotics Improved Canine Feed Intake, Weight Gain, Immunity and Intestinal Microbiota

Pre- and Probiotics to Increase the Immune Power of Colostrum in Dogs

Oat beta-glucan as a dietary supplement for dogs

Impact of Pediococcus acidilactici GLP06 supplementation on gut microbes and metabolites in adult beagles: a comparative analysis

Prebiotic Oligosaccharides Change the Concentrations of Short-Chain Fatty Acids and the Microbial Population of Mouse Bowel.

Dried yeast cell walls high in beta-glucan and mannan-oligosaccharides positively affect microbial composition and activity in the canine gastrointestinal tract in vitro

Optimization for Galactooligosaccharides Synthesis: A Potential Alternative for Gut Health and Immunity

In Vitro Assessment of Postbiotic and Probiotic Commercial Dietary Supplements Recommended for Counteracting Intestinal Dysbiosis in Dogs